Highlighted research
My first-author publication was selected to be on the front cover of the ChemMedChem scientific journal!
The Front Cover shows the combinatorial approach of development, testing, and validation of novel N-heterocyclic DYRK1A inhibitors. An initial in silico investigation of the toxic DYRK1A inhibitor, harmine, within the active site of DYRK1A inspired generation of diverse molecular scaffolds. Scaffolds tested in vitro for inhibition of DYRK1A were substantiated in an in vivo model organism. This study serves as a platform for future investigations into treatments for disorders associated with genetic DYRK1A dysregulation. Cover design by Francisco J. Huizar.
Purpose statement
-
I am a collaborative cross-functional scientist with expertise in computational biology, mathematical modeling, science-based decision making, and interdisciplinary communication.
-
The core mission of my professional endeavors is to serve patients afflicted by genetic-related disease with therapeutic approaches and innovative biotechnology in a clinical setting.
-
To achieve my mission of service, I aim to utilize my talents of communication and execution to perform my passion of planning and analyzing by using data-driven approaches for drug discovery.
-
Helping, guiding, leading, lifting, and loving others fills my heart, gives me motivation, and creates unbounding feelings of significance.
Summary of qualifications
-
Articulate communicator with expertise in data visualization and scientific presentation resulting in 1 academic journal front cover, 14 conference and 5 seminar presentations.
-
Self-motivated project manager with excellent communication, innovation, and strategic planning abilities resulting in 4 first-author publications and 5 fellowships totaling $96,000 in funding.
-
Versatile learner committed to professional development as demonstrated by integration of 3 computational modeling, pharmacometrics, and clinical drug development training workshops.
-
Inspiring leader with expertise in fostering patience, encouragement, collaborative environments, and collective success as evidenced by mentoring 8 undergraduate and 9 graduate students.
-
Dedicated and dependable scientist committed to integrity and accountability resulting in 3 discoveries in therapeutic research for oncology and neurodegenerative preclinical disease models.
“Everything can be taken from a man but one thing: the last of the human freedoms—to choose one’s attitude in any given set of circumstances, to choose one’s own way.”
​
“When we are no longer able to change a situation, we are challenged to change ourselves.”
-Â Victor Frankl
Contact
100 McCourtney Hall
231 ZARTMAN LAB Building
MCCO
South Bend, Indiana 46556
United States